Mediawire Newsletters Alerts E-Paper E-Learning ET Alexa Skills ET intelligence Mobile ET Android App ET iPhone App ET iPad App ET Wealth for iPad ET Blackberry App ET Nokia App ET Markets Android App ET Markets iPhone App

Brand Solutions

ET Markets Conclave – Cryptocurrency

The Night of Ideas: 24 Hours Live to Feel "Closer"

The Economic Times Digital Payments Forum

The Economic Times Startup Awards 2020

Reshape Tomorrow

Tomorrow is different. Let's reshape it today

ET Campus Stars

Hunt for the brightest engineers in India

ET Prime Women Leadership Awards

Great Manager Awards

Auto

Auto News

Cars & UVs

Two wheelers & three wheelers

Fashion / Cosmetics / Jewellery

Paper / Wood / Glass/ Plastic/ Marbles

Property / C'struction

Transportation Railways Airlines / Aviation Shipping / Transport Roadways Tech ITES Tech & Internet Startups Funding Tech Bytes Telecom Telecom News Telecom Policy Miscellaneous CSR Initiatives Policy Environment

Business News›Industry›Healthcare/Biotech›Pharmaceuticals›Covid-19: US regulators recommend 'pause' in use of Johnson & Johnson vaccine over blood clot reports

ET Healthcare/Biotech NEWS

Covid-19: US regulators recommend 'pause' in use of Johnson & Johnson vaccine over blood clot reports

Mirror Now | 13 Apr 2021, 06:36 PM IST

Post a Comment

Copy URL

Embed

<iframe mozallowfullscreen="true" webkitallowfullscreen="true" allowfullscreen="true" width="560" height="420" frameborder="0" src=""></iframe>

Top US health authorities recommended a "pause" in the use of the Johnson & Johnson Covid-19 vaccine "out of an abundance of caution" as they investigate any links between it and blood clots, a regulator said Tuesday.

Follow @EconomicTimes

12views

Read more on

Johnson & Johnson

blood clots

coronavirus vaccination drive

US health authorities

03:54
Over 1,67,20,000 unutilised doses with states/UTs; Issue is better planning & not shortage: Union Health Secy
Views: 53
07:30
Govt fast-tracks emergency approvals for foreign-produced Covid-19 vaccines
Views: 241
20:55
Exclusive interview with Serum Institute's Adar Poonawalla
Views: 2435
01:44
Covid-19: DCGI extends shelf life of Covishield to 9 months from manufacturing date
Views: 1910
02:49
COVID Vaccination: India revises interval between 2 doses of Covishield, can be taken between 4-8 weeks
Views: 21815
01:23
India to manufacture Johnson & Johnson’s Covid-19 vaccine as part of Quad initiative
Views: 5466
01:28
Drugs Controller General accepts expert committee report to allow Covaxin jabs without clinical trial
Views: 1052
02:32
Phase 3 clinical trial: Bharat Biotech says COVID-19 vaccine shows 81% interim efficacy
Views: 3959
01:44
Serum Institute says it's prioritising domestic vaccine needs, urges countries to be patient
Views: 1314
01:34
Post Covid-19, Ayurveda economy risen 50-90%: Harsh Vardhan
Views: 679
01:32
Baba Ramdev launches Patanjali's 'evidence-based' medicine for Covid-19
Views: 10805
01:48
Pfizer withdraws application for emergency use authorization of its Covid vaccine in India
Views: 799
00:38
Covid-19: Bharat Biotech, Ocugen ink deal for Covaxin supply to US
Views: 7241
03:21
Fire breaks out at Terminal 1 gate of Pune Serum Institute of India
Views: 7343
02:47
Immunocompromised people advised not to take Covaxin: Bharat Biotech releases detailed factsheet
Views: 2022
01:43
Covid vaccination drive: Bharat Biotech to pay compensation if Covaxin causes side effects
Views: 3723
01:51
Covishield gets conditional approval from Expert panel, waiting for DCGI's final approval
Views: 1714
03:37
Covid-19: Oxford vaccine likely to be first to get India's nod for emergency use
Views: 2202
03:44
BioNTech CEO says Covid-19 vaccine could work against new strain in UK
Views: 465
01:59
Covid-19: India's first indigenous mRNA vaccine gets DCGI nod for human trial
Views: 2854
03:56
COVID vaccines in India: 6 candidates in different trial stages, 3 may get licensed in 'next few weeks'
Views: 3555
01:49
Covid-19: Serum Institute seeks emergency authorisation for Oxford vaccine Covishield in India
Views: 707
01:30
Covid-19 vaccine: Oxford trials show 70 per cent efficacy
Views: 405
01:28
Pfizer claims final trials of Covid-19 vaccine 95 per cent effective
Views: 670
01:35
Coronavirus Vaccine: Moderna says its COVID-19 shot is nearly 95% effective
Views: 1091
00:48
COVID-19 vaccine is over 90% effective: Pfizer, BioNTech say after early data of phase 3 trials
Views: 1522
01:56
Data breach prompts Dr Reddy's to shut key plants
Views: 3439
02:26
India can get COVID-19 vaccine early next year: Harsh Vardhan in Rajya Sabha
Views: 1159
11:50
With approvals Sputnik V delivery in India possible by end of 2020: Kirill Dmitriev, CEO, RDIF
Views: 3711
01:55
Serum Institute pauses India trials of AstraZeneca's COVID-19 vaccine after DCGI's notice
Views: 1155
02:31
AstraZeneca pauses COVID-19 vaccine trial in UK due to unexplained illness of participant
Views: 1179
07:53
Why are retailers like Amazon, Reliance eyeing e-pharma space?
Views: 1506
09:49
J&J - Bio E aims to manufacture 400mn doses of Covid vaccine in a year: Paul Stoffels
Views: 1838
03:10
Will Trump's ‘Make in America’ order for essential medicines hurt Indian pharma?
Views: 1498
09:24
ET Global Townhall: Pharma and Health sector assets of strategic value, says Ajay Piramal
Views: 1190
02:25
COVID-19 treatment: Trump again defends hydroxychloroquine, says he took it for 14 days
Views: 5529
01:37
Final-stage testing of Moderna’s COVID vaccine begins on 30,000 volunteers
Views: 4849
01:46
COVID-19 vaccine: Part 1 of phase-1 Covaxin trial completed, results encouraging, says Rohtak PGI Doctor
Views: 2438
05:14
Oxford University Coronavirus vaccine: Why it raises hope
Views: 6283